Modulated radiotherapy can cut treatment time for cancer of the rectum without increasing toxicity

... radiotherapy and chemotherapy simultaneously causes about a 30% enteritis rate (inflammation of the intestine). However, in the study, we observed that the application of modulated radiotherapy reduces the rate of enteritis practically to the minimum in the patient who is being treated for bowel ...

DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial ...

Poultry and diabetics at risk from gas gangrene bug

... Harrogate today (Monday, 30 March) that Clostridium perfringens, the bacterium responsible for gas gangrene in people, can also cause necrotic enteritis in intensively raised chickens. This frequently fatal disease has significant financial implications for the poultry industry. Intensive study of ...

DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of Oral BDP in radiation enteritis in 1H 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in the prevention ...

What is the pathogenesis of C. jejuni-related disease?

... from patients with Campylobacter infection had different effects. Nineteen consecutive strains from community patients with acute bacterial enteritis were isolated and three of them were compared with the laboratory strain 12189. All strains translocated across monolayers but only a minority ...

Enteritis in Medical Technology

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial ...

DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial ...

Enteritis in Medical Dictionary

Campylobacter enteritis

... Campylobacter enteritis is an infection in the small intestine ... Jejuni Organ ism ... Campylobacter enteritis is caused by either of two species of the ... and last one to two weeks. Salmonella enteritis Shigella ...

E. coli enteritis

... E. coli enteritis Definition: E. coli enteritis is an inflammation of the small intestine ... coli (E. coli) bacteria . Coli; E. Coli enteritis ; ecological chemistry; ecological ectocrine; ...

Enteritis

... enteritis Related Category: Pathology ... of the gastrointestinal tract. enteritis Definition enteritis is an inflammation of the small intestine ...

Entero

... Mfg: E-Z-EM, Inc. enteric virus es; enteritis ; enteritis anaphylactica; enteritis , crohn's; ...

Gastroenteritis

... causes are: ... More on Gastroenteritis enteritis - inflammation of the gastrointestinal tract. Acute enteritis is not usually serious except in infants and ... polyps Crohn& acute ;s disease (regional enteritis ) Hirschsprung& acute ;s disease intestinal ...

Ileitis

... , Inflammatory Bowel Disease , Regional enteritis See all Pictures & Images Crohn's Disease ... bowel disease - Crohn's disease ; Regional enteritis ; Ileitis ; Granulomatous ileo colitis Receive ... disease is also called ileitis or regional enteritis . ...

Radiation enteritis

... Radiation enteritis Definition: enteritis occurs when the lining of the small intestine ... the abdomen to radiation can cause radiation enteritis . Anyone whose cancer requires radiation ...

Salmonella

... enteritidis paratyphi A, B or C. Salmonella enteritis Shigella enteritis Staph aureus food poisoning Campylobacter enteritis E. coli ...

Shigellosis

... fail to wash their hands properly. Shigella enteritis Shigella Gastroenteritis ( Shigella enteritis ) Shigellosis ( Shigella enteritis ) Shin Splints Shingles ( Herpes Zoster ) ... ...

Campylobacter

... also can cause fever and abdominal cramps . Campylobacter enteritis is an infection in the small intestine caused by Campylobacter ... cramps , nausea , diarrhea and vomiting ... Campylobacter enteritis is caused by either of two species of the Campylobacter bacterium. The ...

More>>

Enteritis in Biological News

New infant formula safety advice could prevent infant suffering

... isolated from the environment and various food products including infant formula. These bacteria have been associated with infant meningitis, enteritis and septicaemia, so prevention of infant's consumption is vital in maintaining their safety. These bugs will grow at 25C or 37C, but less so when ...

Enteritis in Biological Technology

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

... the treatment and prevention of GVHD, the prevention of acute radiation enteritis and the treatment of Crohn's disease. "The FDA's decision to ... of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an ...

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial ...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

... a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in acute radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial ...

DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial ...

DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial ...

DOR BioPharma Appoints Gregg Lapointe, CPA, MBA, to its Board of Directors

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the first half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in ...

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

... to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the first half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in ...